April 27, 2012
A California federal judge charged Thursday that there were signs of collusion in a proposed $12 million class settlement in another court resolving false advertising claims against homeopathic medicine giant Boiron Inc., but stayed a similar suit in order to avoid the specter of conflicting rulings.